Statistics for CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
Total visits
| views | |
|---|---|
| CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. | 111 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| 39A. 2013 blood, CD30 DLBCL, 03-06-2013.pdf | 67 |
| 39B. 2013 Blood, CD30 DLBCL, KHY, 03-06-2013.pdf | 51 |
Top country views
| views | |
|---|---|
| Germany | 6 |
| United Kingdom | 3 |
| United States | 3 |
| Singapore | 2 |
| China | 1 |
| Spain | 1 |
| South Korea | 1 |
Top city views
| views | |
|---|---|
| Changi | 2 |
| Fairfield | 1 |
| Madrid | 1 |
| Old Bridge | 1 |
| Shelton | 1 |